Cargando…
Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB(1)) Receptor
The G protein-coupled type 1 cannabinoid receptor (CB(1)R) mediates virtually all classic cannabinoid effects, and both its agonists and antagonists hold major therapeutic potential. Heterologous expression of receptors is vital for pharmacological research, however, overexpression of these proteins...
Autores principales: | Horváth, Viktória B., Soltész-Katona, Eszter, Wisniewski, Éva, Rajki, Anikó, Halász, Eszter, Enyedi, Balázs, Hunyady, László, Tóth, András Dávid, Szanda, Gergő |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564136/ https://www.ncbi.nlm.nih.gov/pubmed/34745007 http://dx.doi.org/10.3389/fendo.2021.740913 |
Ejemplares similares
-
Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3
por: Szanda, Gergő, et al.
Publicado: (2023) -
Biased Coupling to β-Arrestin of Two Common Variants of the CB(2) Cannabinoid Receptor
por: Turu, Gábor, et al.
Publicado: (2021) -
Role of CB1 Cannabinoid Receptors in Vascular Responses and Vascular Remodeling of the Aorta in Female Mice
por: Bányai, Bálint, et al.
Publicado: (2023) -
The Effect of OPA1 on Mitochondrial Ca(2+) Signaling
por: Fülöp, László, et al.
Publicado: (2011) -
Signaling Interactions in the Adrenal Cortex
por: Spät, András, et al.
Publicado: (2016)